Free Trial

Parsons (PSN) Financials

Parsons logo
$51.17 +0.83 (+1.65%)
Closing price 05/14/2026 03:59 PM Eastern
Extended Trading
$51.20 +0.02 (+0.04%)
As of 07:03 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Annual Income Statements for Parsons

Annual Income Statements for Parsons

This table shows Parsons' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/29/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
97 222 121 99 64 97 161 235 241
Consolidated Net Income / (Loss)
112 239 137 119 89 127 208 291 309
Net Income / (Loss) Continuing Operations
112 239 137 119 89 127 208 291 309
Total Pre-Tax Income
133 260 67 161 113 166 264 368 383
Total Operating Income
151 205 92 178 132 186 288 428 418
Total Gross Profit
617 766 832 877 853 947 1,206 1,406 1,432
Total Revenue
3,017 3,561 3,955 3,919 3,661 4,195 5,443 6,751 6,364
Operating Revenue
3,017 3,561 3,955 3,919 3,661 4,195 5,443 6,751 6,364
Total Cost of Revenue
2,400 2,795 3,123 3,042 2,808 3,249 4,237 5,344 4,933
Operating Cost of Revenue
2,400 2,795 3,123 3,042 2,808 3,249 4,237 5,344 4,933
Total Operating Expenses
466 560 740 699 720 761 918 978 1,013
Selling, General & Admin Expense
506 597 781 729 757 777 870 955 1,016
Other Operating Expenses / (Income)
-40 -37 -42 -30 -37 -16 48 23 -2.58
Total Other Income / (Expense), net
-18 55 -25 -16 -20 -19 -24 -60 -36
Interest Expense
16 21 24 21 18 23 31 52 51
Interest & Investment Income
2.47 2.71 1.30 0.79 0.40 0.97 2.19 11 6.88
Other Income / (Expense), net
-4.37 73 -2.39 3.77 -2.56 2.78 5.00 -20 8.86
Income Tax Expense
21 20 -70 42 24 40 56 77 74
Net Income / (Loss) Attributable to Noncontrolling Interest
14 17 17 20 25 30 47 56 68
Basic Earnings per Share
$1.16 $2.78 $1.30 $0.98 $0.62 $0.93 $1.53 $2.21 $2.26
Weighted Average Basic Shares Outstanding
- - 100.67M 102.36M 103.67M 104.71M 105.83M 106.78M 105.83M
Diluted Earnings per Share
$1.16 $2.78 $1.30 $0.97 $0.59 $0.87 $1.42 $2.12 $2.20
Weighted Average Diluted Shares Outstanding
- - 100.67M 102.36M 103.67M 104.71M 105.83M 106.78M 105.83M
Weighted Average Basic & Diluted Shares Outstanding
- - 100.67M 102.36M 103.67M 104.71M 105.83M 106.78M 105.83M

Quarterly Income Statements for Parsons

This table shows Parsons' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders
47 45 40 69 72 201 66 55 64 56 53
Consolidated Net Income / (Loss)
60 58 55 81 86 216 82 70 82 75 65
Net Income / (Loss) Continuing Operations
60 58 55 81 86 216 82 70 82 75 65
Total Pre-Tax Income
75 72 68 103 108 281 101 89 98 95 81
Total Operating Income
83 77 102 111 115 100 109 96 108 105 96
Total Gross Profit
294 367 325 352 360 370 354 348 360 369 357
Total Revenue
1,419 1,494 1,536 1,670 1,810 1,734 1,554 1,584 1,622 1,604 1,491
Operating Revenue
1,419 1,494 1,536 1,670 1,810 1,734 1,554 1,584 1,622 1,604 1,491
Total Cost of Revenue
1,124 1,127 1,211 1,319 1,450 1,365 1,200 1,236 1,262 1,234 1,134
Operating Cost of Revenue
1,124 1,127 1,211 1,319 1,450 1,365 1,200 1,236 1,262 1,234 1,134
Total Operating Expenses
211 290 223 240 245 247 245 253 252 264 262
Selling, General & Admin Expense
221 238 221 223 246 265 244 252 260 260 268
Other Operating Expenses / (Income)
-10 52 2.06 17 -0.87 - 0.69 0.64 -8.27 4.35 -6.16
Total Other Income / (Expense), net
-8.31 -5.19 -34 -8.29 -6.88 158 -8.47 -6.48 -10 -10 -14
Interest Expense
8.61 9.13 13 13 13 -180 12 13 14 13 16
Interest & Investment Income
0.49 0.60 1.15 3.83 4.23 -21 2.14 1.07 1.84 1.83 1.81
Other Income / (Expense), net
-0.19 3.34 -22 0.90 1.92 -1.40 1.64 5.02 1.57 0.64 -0.19
Income Tax Expense
15 14 13 22 23 64 19 19 16 20 16
Net Income / (Loss) Attributable to Noncontrolling Interest
12 13 15 12 14 15 16 15 18 19 12
Basic Earnings per Share
$0.45 $0.43 $0.37 $0.65 $0.68 $1.89 $0.62 $0.52 $0.60 $0.52 $0.49
Weighted Average Basic Shares Outstanding
104.89M 105.83M 146.75M 106.19M 106.19M 106.78M 106.87M 106.79M 106.49M 105.83M 106.98M
Diluted Earnings per Share
$0.42 $0.39 $0.37 $0.63 $0.65 $1.85 $0.60 $0.50 $0.59 $0.51 $0.49
Weighted Average Diluted Shares Outstanding
104.89M 105.83M 146.75M 106.19M 106.19M 106.78M 106.87M 106.79M 106.49M 105.83M 106.98M
Weighted Average Basic & Diluted Shares Outstanding
104.89M 105.83M 146.75M 106.19M 106.19M 106.78M 106.87M 106.79M 106.49M 105.83M 106.98M

Annual Cash Flow Statements for Parsons

This table details how cash moves in and out of Parsons' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/29/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
53 -165 -86 292 -143 -81 10 181 13
Net Cash From Operating Activities
265 285 220 289 206 238 408 524 478
Net Cash From Continuing Operating Activities
265 285 220 289 206 238 408 524 478
Net Income / (Loss) Continuing Operations
112 239 137 119 89 127 208 291 309
Consolidated Net Income / (Loss)
112 239 137 119 89 127 208 291 309
Depreciation Expense
35 70 126 128 144 121 120 99 116
Amortization Expense
-6.78 -6.53 0.97 5.19 2.82 3.03 2.84 7.80 5.06
Non-Cash Adjustments To Reconcile Net Income
59 -364 27 60 65 60 154 237 22
Changes in Operating Assets and Liabilities, net
66 346 -71 -23 -95 -72 -77 -112 26
Net Cash From Investing Activities
-53 -503 -571 -346 -241 -417 -376 -557 -256
Net Cash From Continuing Investing Activities
-53 -503 -571 -346 -256 -417 -376 -557 -256
Purchase of Property, Plant & Equipment
-28 -29 -68 -34 -21 -31 -40 -49 -68
Acquisitions
-29 -486 -519 -314 -237 -397 -342 -563 -229
Sale of Property, Plant & Equipment
2.25 0.44 3.79 1.55 1.33 0.77 0.55 0.18 0.84
Divestitures
- - 0.00 0.00 0.00 0.00 0.38 0.00 0.00
Sale and/or Maturity of Investments
1.97 11 12 0.05 0.77 9.44 5.02 55 40
Net Cash From Financing Activities
-160 55 266 348 -107 100 -22 219 -214
Net Cash From Continuing Financing Activities
-160 55 266 348 -102 100 -22 219 -214
Repayment of Debt
-1.95 -81 -777 -223 -50 -1,171 -621 -172 -596
Repurchase of Preferred Equity
- - - - - 0.00 0.00 -498 -113
Repurchase of Common Equity
- - -6.27 0.00 -22 -33 -11 -25 -125
Payment of Dividends
-51 -19 -94 -5.82 -38 -24 -12 -29 -63
Issuance of Debt
0.00 260 597 613 0.00 1,320 621 953 694
Issuance of Common Equity
7.48 21 547 20 7.31 16 8.93 10 10
Other Financing Activities, net
-114 -126 0.00 -56 0.00 -7.04 -7.30 -20 -20
Effect of Exchange Rate Changes
1.24 -1.70 -1.29 0.82 -1.50 -1.77 0.55 -5.04 4.14
Cash Interest Paid
13 17 23 14 15 21 30 34 44

Quarterly Cash Flow Statements for Parsons

This table details how cash moves in and out of Parsons' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents
27 68 150 105 30 -105 -184 142 11 44 -182
Net Cash From Operating Activities
204 190 -63 161 299 127 -12 160 163 168 -3.70
Net Cash From Continuing Operating Activities
204 190 -63 161 299 127 -12 160 163 168 -3.70
Net Income / (Loss) Continuing Operations
60 58 55 81 86 216 82 70 82 75 65
Consolidated Net Income / (Loss)
60 58 55 81 86 216 82 70 82 75 65
Depreciation Expense
30 33 25 24 25 26 27 29 30 31 36
Amortization Expense
0.71 0.72 4.10 1.23 1.24 1.24 1.22 1.39 1.22 1.22 1.21
Non-Cash Adjustments To Reconcile Net Income
-7.43 179 53 11 60 -90 -36 22 45 -8.11 -62
Changes in Operating Assets and Liabilities, net
120 -80 -200 44 128 -27 -86 37 5.04 69 -44
Net Cash From Investing Activities
-243 -49 -46 -43 -256 -212 -62 -103 -24 -67 -365
Net Cash From Continuing Investing Activities
-243 -49 -46 -43 -256 -212 -62 -103 -24 -67 -365
Purchase of Property, Plant & Equipment
-13 -9.52 -9.44 -9.26 -12 -19 -13 -9.44 -13 -32 -15
Acquisitions
-230 -44 -36 -34 -244 -248 -48 -105 -27 -48 -357
Sale and/or Maturity of Investments
- 4.95 - - - 55 0.00 - 16 12 7.54
Net Cash From Financing Activities
67 -74 260 -12 -13 -15 -111 82 -127 -58 186
Net Cash From Continuing Financing Activities
67 -74 260 -12 -13 -15 -111 82 -127 -58 186
Repayment of Debt
-249 -184 -172 -0.24 - 800 -146 -450 - - -76
Repurchase of Preferred Equity
- - -496 - -0.02 -2.02 -28 -0.01 -85 - 0.00
Repurchase of Common Equity
- -3.00 0.00 -10 - -15 -25 -15 -25 -60 -35
Payment of Dividends
-9.67 -0.34 -11 -3.99 -14 -0.19 -42 -3.05 -18 -0.45 -34
Issuance of Debt
324 109 953 - - -800 146 548 - - 350
Issuance of Common Equity
1.34 4.45 0.00 3.82 0.96 5.33 0.26 4.86 1.18 4.16 0.81
Other Financing Activities, net
-0.10 -0.36 -15 -2.03 -0.29 -3.33 -16 -2.57 -0.75 -1.36 -20
Effect of Exchange Rate Changes
-0.30 0.38 -0.40 -0.24 0.33 -4.72 0.52 2.75 -0.35 1.23 -0.67

Annual Balance Sheets for Parsons

This table presents Parsons' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets
2,613 3,450 3,938 3,831 4,198 4,804 5,488 5,770
Total Current Assets
1,489 1,526 1,843 1,632 1,720 2,138 2,462 2,684
Cash & Equivalents
280 183 484 343 263 273 454 466
Accounts Receivable
623 671 699 598 717 916 1,100 1,124
Prepaid Expenses
69 84 81 111 106 191 167 177
Other Current Assets
515 575 577 579 634 758 742 916
Plant, Property, & Equipment, net
92 123 121 104 96 99 112 151
Total Noncurrent Assets
1,032 1,801 1,974 2,094 2,382 2,568 2,914 2,935
Long-Term Investments
64 69 69 111 107 128 139 149
Goodwill
737 1,047 1,262 1,413 1,662 1,793 2,083 2,187
Intangible Assets
180 260 246 208 254 276 350 326
Noncurrent Deferred & Refundable Income Taxes
5.68 130 130 134 138 140 133 88
Other Noncurrent Operating Assets
46 295 266 229 221 231 209 186
Total Liabilities & Shareholders' Equity
2,613 3,450 3,938 3,831 4,198 4,804 5,488 5,770
Total Liabilities
1,657 1,790 2,076 1,894 2,102 2,427 2,953 3,002
Total Current Liabilities
1,006 1,144 1,187 1,031 1,108 1,411 1,916 1,532
Short-Term Debt
- 0.00 50 - 59 0.00 463 45
Accounts Payable
226 217 226 196 201 243 208 251
Accrued Expenses
560 640 651 599 630 801 894 884
Current Deferred Revenue
209 231 202 172 213 301 290 340
Current Deferred & Payable Income Tax Liabilities
12 7.23 4.98 7.84 4.29 6.98 7.70 11
Total Noncurrent Liabilities
651 645 889 863 994 1,016 1,038 1,470
Long-Term Debt
429 249 540 592 744 746 784 1,238
Capital Lease Obligations
46 - - 149 111 118 114 94
Noncurrent Deferred & Payable Income Tax Liabilities
6.24 9.62 12 11 12 9.78 11 12
Other Noncurrent Operating Liabilities
170 386 337 111 127 143 128 126
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
-921 1,661 1,861 1,937 2,096 2,377 2,534 2,768
Total Preferred & Common Equity
-968 1,630 1,814 1,901 2,044 2,287 2,416 2,642
Total Common Equity
-968 1,630 1,814 1,901 2,044 2,287 2,416 2,642
Common Stock
0.00 2,796 2,848 2,831 2,863 2,926 2,831 2,794
Retained Earnings
12 -218 -121 -54 43 204 427 661
Treasury Stock
-957 -934 -899 -867 -845 -827 -815 -793
Accumulated Other Comprehensive Income / (Loss)
-23 -14 -14 -9.57 -18 -15 -27 -21
Noncontrolling Interest
46 31 48 36 52 90 118 126

Quarterly Balance Sheets for Parsons

This table presents Parsons' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets
4,095 4,256 4,508 4,733 5,098 5,239 5,443 5,449 5,721 5,737 6,012
Total Current Assets
1,611 1,801 1,980 2,016 2,427 2,574 2,555 2,401 2,594 2,649 2,594
Cash & Equivalents
148 220 179 205 423 528 559 270 411 423 284
Accounts Receivable
711 764 949 907 1,023 1,043 1,035 1,125 1,168 1,224 1,097
Prepaid Expenses
110 134 140 147 213 199 171 184 178 180 192
Other Current Assets
642 684 712 757 768 804 790 823 836 822 1,022
Plant, Property, & Equipment, net
95 95 95 99 98 98 101 122 123 126 155
Total Noncurrent Assets
2,390 2,360 2,432 2,618 2,573 2,567 2,787 2,926 3,005 2,962 3,263
Long-Term Investments
99 107 119 165 145 157 195 142 151 156 162
Goodwill
1,661 1,662 1,693 1,797 1,791 1,791 1,931 2,107 2,162 2,163 2,424
Intangible Assets
273 236 240 282 262 248 308 340 361 339 408
Noncurrent Deferred & Refundable Income Taxes
140 140 145 149 158 163 164 132 134 107 60
Other Noncurrent Operating Assets
216 214 235 225 217 208 190 205 196 196 209
Total Liabilities & Shareholders' Equity
4,095 4,256 4,508 4,733 5,098 5,239 5,443 5,449 5,721 5,737 6,012
Total Liabilities
2,090 2,130 2,317 2,485 2,855 2,919 3,029 2,903 3,100 3,072 3,258
Total Current Liabilities
1,149 1,140 1,295 1,394 1,354 1,427 1,650 1,865 1,608 1,588 1,480
Short-Term Debt
- 56 57 57 55 53 115 435 85 0.00 43
Accounts Payable
201 209 237 266 274 253 300 289 288 271 233
Accrued Expenses
683 635 694 772 739 822 877 784 848 912 832
Current Deferred Revenue
198 229 292 277 283 298 - 298 320 344 360
Current Deferred & Payable Income Tax Liabilities
9.15 11 15 22 2.37 1.04 4.56 7.69 13 11 13
Total Noncurrent Liabilities
940 990 1,022 1,091 1,502 1,492 1,379 1,038 1,492 1,484 1,778
Long-Term Debt
695 744 745 820 1,246 1,247 1,133 785 1,236 1,237 1,513
Capital Lease Obligations
121 107 129 119 107 98 98 108 100 98 121
Noncurrent Deferred & Payable Income Tax Liabilities
10 13 20 20 9.76 9.79 28 11 19 18 12
Other Noncurrent Operating Liabilities
114 126 128 131 139 137 121 133 137 132 132
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
2,005 2,126 2,191 2,248 2,243 2,320 2,414 2,546 2,622 2,665 2,754
Total Preferred & Common Equity
1,953 2,064 2,119 2,173 2,150 2,219 2,312 2,454 2,516 2,558 2,650
Total Common Equity
1,953 2,064 2,119 2,173 2,150 2,219 2,312 2,454 2,516 2,558 2,650
Common Stock
2,825 2,858 2,868 2,876 2,907 2,909 2,929 2,807 2,807 2,792 2,756
Retained Earnings
15 68 112 159 87 156 227 488 542 606 710
Treasury Stock
-867 -845 -845 -845 -827 -827 -827 -815 -815 -815 -793
Accumulated Other Comprehensive Income / (Loss)
-19 -18 -15 -17 -17 -19 -16 -26 -18 -24 -23
Noncontrolling Interest
52 62 71 75 93 101 102 92 106 107 105

Annual Metrics And Ratios for Parsons

This table displays calculated financial ratios and metrics derived from Parsons' official financial filings.

Metric 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/29/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - - - - - - - -
Revenue Growth
0.00% 18.01% 11.07% -0.91% -6.59% 14.60% 29.74% 24.03% -5.72%
EBITDA Growth
0.00% 95.29% -36.61% 45.49% -12.02% 12.66% 33.40% 28.12% 6.53%
EBIT Growth
0.00% 89.93% -67.74% 102.50% -28.47% 45.08% 55.68% 45.27% 4.69%
NOPAT Growth
0.00% 49.50% -0.63% -30.22% -20.12% 35.10% 60.61% 49.05% -0.25%
Net Income Growth
0.00% 114.67% -42.73% -13.28% -25.20% 42.28% 64.28% 39.80% 6.26%
EPS Growth
0.00% 139.66% -53.24% -25.38% -39.18% 47.46% 63.22% 49.30% 3.77%
Operating Cash Flow Growth
0.00% 7.40% -22.62% 31.29% -28.91% 15.54% 71.64% 28.43% -8.64%
Free Cash Flow Firm Growth
0.00% 0.00% 58.43% 68.31% -89.23% -23.23% 110.22% -549.69% 224.12%
Invested Capital Growth
0.00% 0.00% 51.63% 15.13% 17.31% 18.75% 7.53% 16.38% 5.46%
Revenue Q/Q Growth
0.00% 0.00% 2.82% -1.83% -0.37% 3.77% 7.74% 3.69% -2.01%
EBITDA Q/Q Growth
0.00% 0.00% 6.38% 7.69% 1.73% 3.00% 5.41% 2.13% -1.09%
EBIT Q/Q Growth
0.00% 0.00% 1.56% 12.36% 1.63% 9.59% 6.84% 4.32% -2.49%
NOPAT Q/Q Growth
0.00% 0.00% 1.07% 3.16% 11.07% 2.64% 8.52% 0.38% 1.33%
Net Income Q/Q Growth
0.00% 0.00% 6.26% 4.02% 11.59% 0.16% 11.66% 119.78% 1.79%
EPS Q/Q Growth
0.00% 0.00% 4.00% 4.30% 9.26% -2.25% 11.81% 221.21% 1.85%
Operating Cash Flow Q/Q Growth
0.00% 0.00% -30.18% 42.41% -29.46% -0.29% 32.92% -10.80% 9.31%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% -230.99% 26.52% 25.64% 130.88% -161.99% 297.50%
Invested Capital Q/Q Growth
0.00% 0.00% 0.94% 13.65% 7.62% 2.57% -1.23% 9.87% 1.88%
Profitability Metrics
- - - - - - - - -
Gross Margin
20.45% 21.50% 21.03% 22.37% 23.30% 22.57% 22.16% 20.83% 22.49%
EBITDA Margin
5.79% 9.58% 5.47% 8.03% 7.56% 7.44% 7.65% 7.90% 8.62%
Operating Margin
5.00% 5.76% 2.33% 4.54% 3.62% 4.43% 5.30% 6.34% 6.57%
EBIT Margin
4.85% 7.81% 2.27% 4.63% 3.55% 4.49% 5.39% 6.31% 6.71%
Profit (Net Income) Margin
3.70% 6.72% 3.47% 3.03% 2.43% 3.02% 3.82% 4.31% 4.85%
Tax Burden Percent
83.86% 92.16% 203.93% 73.68% 79.01% 76.14% 78.74% 79.06% 80.75%
Interest Burden Percent
90.89% 93.48% 74.99% 88.89% 86.68% 88.21% 90.01% 86.27% 89.59%
Effective Tax Rate
16.14% 7.84% -103.93% 26.33% 20.99% 23.86% 21.26% 20.94% 19.25%
Return on Invested Capital (ROIC)
0.00% 34.81% 13.75% 7.40% 5.08% 5.81% 8.29% 11.02% 9.95%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 112.25% -73.70% -118.69% -4.72% 2.25% 4.49% 3.26% 6.08%
Return on Net Nonoperating Assets (RNNOA)
0.00% 15.33% -3.26% -0.65% -0.40% 0.46% 1.01% 0.82% 1.71%
Return on Equity (ROE)
0.00% 50.13% 10.48% 6.75% 4.68% 6.28% 9.30% 11.84% 11.65%
Cash Return on Invested Capital (CROIC)
0.00% -165.19% -27.29% -6.67% -10.85% -11.33% 1.03% -4.12% 4.63%
Operating Return on Assets (OROA)
0.00% 10.64% 2.96% 4.92% 3.34% 4.69% 6.52% 8.28% 7.58%
Return on Assets (ROA)
0.00% 9.16% 4.52% 3.22% 2.29% 3.15% 4.62% 5.65% 5.49%
Return on Common Equity (ROCE)
0.00% -50.78% 2.65% 6.60% 4.58% 6.14% 9.00% 11.34% 11.11%
Return on Equity Simple (ROE_SIMPLE)
0.00% -24.75% 8.41% 6.56% 4.68% 6.19% 9.09% 12.03% 0.00%
Net Operating Profit after Tax (NOPAT)
126 189 188 131 105 141 227 338 338
NOPAT Margin
4.19% 5.31% 4.75% 3.34% 2.86% 3.37% 4.17% 5.01% 5.30%
Net Nonoperating Expense Percent (NNEP)
0.00% -77.45% 87.44% 126.09% 9.80% 3.57% 3.80% 7.75% 3.86%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - 4.70% 7.01% 8.69% 8.23%
Cost of Revenue to Revenue
79.55% 78.50% 78.97% 77.63% 76.70% 77.43% 77.84% 79.17% 77.51%
SG&A Expenses to Revenue
16.78% 16.78% 19.76% 18.60% 20.69% 18.53% 15.98% 14.15% 15.96%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
15.45% 15.74% 18.70% 17.84% 19.68% 18.14% 16.86% 14.15% 15.92%
Earnings before Interest and Taxes (EBIT)
146 278 90 182 130 188 293 426 427
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
175 341 216 315 277 312 416 533 548
Valuation Ratios
- - - - - - - - -
Price to Book Value (P/BV)
0.00 0.00 2.51 2.02 1.81 2.34 2.88 4.05 2.49
Price to Tangible Book Value (P/TBV)
0.00 0.00 12.70 11.99 12.28 37.52 30.04 0.00 50.82
Price to Revenue (P/Rev)
0.17 0.14 1.04 0.94 0.94 1.14 1.21 1.45 1.03
Price to Earnings (P/E)
5.14 2.25 34.00 37.22 53.70 49.52 40.82 41.68 27.29
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
19.47% 44.47% 2.94% 2.69% 1.86% 2.02% 2.45% 2.40% 3.66%
Enterprise Value to Invested Capital (EV/IC)
0.00 2.35 2.50 1.98 1.69 2.04 2.51 3.23 2.13
Enterprise Value to Revenue (EV/Rev)
0.00 0.72 1.04 0.96 1.03 1.28 1.31 1.58 1.17
Enterprise Value to EBITDA (EV/EBITDA)
0.00 7.48 19.02 11.91 13.59 17.26 17.13 20.04 13.53
Enterprise Value to EBIT (EV/EBIT)
0.00 9.19 45.88 20.65 28.98 28.57 24.30 25.07 17.39
Enterprise Value to NOPAT (EV/NOPAT)
0.00 13.51 21.91 28.62 35.97 38.08 31.40 31.57 21.99
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 8.97 18.68 12.96 18.31 22.67 17.49 20.40 15.52
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 0.00 0.00 253.23 0.00 47.24
Leverage & Solvency
- - - - - - - - -
Debt to Equity
0.00 0.50 0.15 0.32 0.38 0.44 0.36 0.54 0.48
Long-Term Debt to Equity
0.00 0.50 0.15 0.29 0.38 0.41 0.36 0.35 0.48
Financial Leverage
0.00 0.14 0.04 0.01 0.08 0.21 0.23 0.25 0.28
Leverage Ratio
0.00 2.74 2.32 2.10 2.05 1.99 2.01 2.10 2.12
Compound Leverage Factor
0.00 2.56 1.74 1.86 1.77 1.76 1.81 1.81 1.90
Debt to Total Capital
0.00% 33.22% 13.05% 24.07% 27.66% 30.37% 26.65% 34.95% 32.49%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 2.04% 0.00% 1.96% 0.00% 11.89% 0.00%
Long-Term Debt to Total Capital
0.00% 33.22% 13.05% 22.03% 27.66% 28.41% 26.65% 23.06% 32.49%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 134.42% 1.62% 1.94% 1.36% 1.74% 2.76% 3.03% 3.07%
Common Equity to Total Capital
0.00% -67.64% 85.33% 73.99% 70.98% 67.89% 70.59% 62.02% 64.45%
Debt to EBITDA
0.00 1.39 1.15 1.87 2.68 2.93 2.07 2.55 2.43
Net Debt to EBITDA
0.00 0.38 -0.07 0.11 1.03 1.74 1.11 1.44 1.31
Long-Term Debt to EBITDA
0.00 1.39 1.15 1.72 2.68 2.74 2.07 1.69 2.43
Debt to NOPAT
0.00 2.52 1.33 4.50 7.08 6.47 3.80 4.02 3.95
Net Debt to NOPAT
0.00 0.69 -0.08 0.26 2.74 3.85 2.04 2.27 2.12
Long-Term Debt to NOPAT
0.00 2.52 1.33 4.12 7.08 6.05 3.80 2.65 3.95
Altman Z-Score
0.00 2.12 2.65 2.36 2.33 2.70 3.20 3.70 3.06
Noncontrolling Interest Sharing Ratio
0.00% 201.29% 74.68% 2.23% 2.21% 2.20% 3.17% 4.23% 4.60%
Liquidity Ratios
- - - - - - - - -
Current Ratio
0.00 1.48 1.33 1.55 1.58 1.55 1.52 1.29 1.75
Quick Ratio
0.00 0.90 0.75 1.00 0.91 0.88 0.84 0.81 1.04
Cash Flow Metrics
- - - - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -897 -373 -118 -223 -275 28 -127 157
Operating Cash Flow to CapEx
1,031.68% 986.80% 345.16% 890.00% 1,039.51% 796.48% 1,023.08% 1,067.84% 712.64%
Free Cash Flow to Firm to Interest Expense
0.00 -43.02 -15.71 -5.64 -12.63 -11.88 0.89 -1.81 3.06
Operating Cash Flow to Interest Expense
16.78 13.66 9.28 13.80 11.62 10.24 12.94 7.49 9.32
Operating Cash Flow Less CapEx to Interest Expense
15.15 12.27 6.59 12.25 10.50 8.96 11.68 6.79 8.02
Efficiency Ratios
- - - - - - - - -
Asset Turnover
0.00 1.36 1.30 1.06 0.94 1.05 1.21 1.31 1.13
Accounts Receivable Turnover
0.00 5.71 6.11 5.72 5.65 6.38 6.67 6.70 5.72
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 38.76 36.86 32.15 32.51 41.90 55.82 64.13 48.46
Accounts Payable Turnover
0.00 12.35 14.10 13.76 13.31 16.34 19.07 23.73 21.54
Days Sales Outstanding (DSO)
0.00 63.90 59.75 63.80 64.65 57.23 54.76 54.50 63.80
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 29.56 25.88 26.53 27.43 22.34 19.14 15.38 16.95
Cash Conversion Cycle (CCC)
0.00 34.34 33.86 37.27 37.23 34.89 35.62 39.12 46.85
Capital & Investment Metrics
- - - - - - - - -
Invested Capital
0.00 1,086 1,646 1,895 2,223 2,640 2,839 3,304 3,485
Invested Capital Turnover
0.00 6.56 2.90 2.21 1.78 1.73 1.99 2.20 1.88
Increase / (Decrease) in Invested Capital
0.00 1,086 560 249 328 417 199 465 180
Enterprise Value (EV)
0.00 2,553 4,114 3,749 3,764 5,384 7,129 10,684 7,423
Market Capitalization
500 500 4,098 3,667 3,441 4,787 6,578 9,796 6,581
Book Value per Share
$0.00 ($52.25) $16.42 $18.01 $18.59 $19.74 $21.81 $22.76 $24.81
Tangible Book Value per Share
$0.00 ($101.74) $3.25 $3.04 $2.74 $1.23 $2.09 ($0.15) $1.22
Total Capital
0.00 1,430 1,910 2,451 2,678 3,010 3,240 3,896 4,100
Total Debt
0.00 475 249 590 741 914 863 1,362 1,332
Total Long-Term Debt
0.00 475 249 540 741 855 863 898 1,332
Net Debt
0.00 130 -15 34 286 544 462 770 717
Capital Expenditures (CapEx)
26 29 64 32 20 30 40 49 67
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 201 187 219 258 408 454 557 685
Debt-free Net Working Capital (DFNWC)
0.00 483 382 706 602 671 727 1,010 1,152
Net Working Capital (NWC)
0.00 483 382 656 602 612 727 547 1,152
Net Nonoperating Expense (NNE)
15 -50 51 12 16 15 19 48 29
Net Nonoperating Obligations (NNO)
0.00 130 -15 34 286 544 462 770 717
Total Depreciation and Amortization (D&A)
28 63 127 133 147 124 123 107 122
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 5.66% 4.72% 5.58% 7.04% 9.73% 8.34% 8.25% 10.77%
Debt-free Net Working Capital to Revenue
0.00% 13.56% 9.66% 18.01% 16.43% 15.99% 13.35% 14.96% 18.10%
Net Working Capital to Revenue
0.00% 13.56% 9.66% 16.73% 16.43% 14.58% 13.35% 8.10% 18.10%
Earnings Adjustments
- - - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $1.30 $0.98 $0.62 $0.93 $1.53 $2.21 $2.26
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 100.67M 102.36M 103.67M 104.71M 105.83M 106.78M 105.83M
Adjusted Diluted Earnings per Share
$0.00 $0.00 $1.30 $0.97 $0.59 $0.87 $1.42 $2.12 $2.20
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 100.67M 102.36M 103.67M 104.71M 105.83M 106.78M 105.83M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 100.67M 102.36M 103.67M 104.71M 105.83M 106.78M 105.83M
Normalized Net Operating Profit after Tax (NOPAT)
126 189 64 131 105 141 227 338 338
Normalized NOPAT Margin
4.19% 5.31% 1.63% 3.34% 2.86% 3.37% 4.17% 5.01% 5.30%
Pre Tax Income Margin
4.41% 7.30% 1.70% 4.12% 3.08% 3.96% 4.85% 5.45% 6.01%
Debt Service Ratios
- - - - - - - - -
EBIT to Interest Expense
9.26 13.34 3.78 8.66 7.34 8.13 9.31 6.09 8.32
NOPAT to Interest Expense
8.00 9.07 7.91 6.25 5.91 6.10 7.21 4.84 6.58
EBIT Less CapEx to Interest Expense
7.64 11.95 1.09 7.11 6.22 6.84 8.05 5.39 7.01
NOPAT Less CapEx to Interest Expense
6.37 7.68 5.22 4.70 4.80 4.81 5.94 4.14 5.27
Payout Ratios
- - - - - - - - -
Dividend Payout Ratio
46.05% 7.89% 68.82% 4.89% 42.64% 19.06% 6.01% 10.05% 20.49%
Augmented Payout Ratio
46.05% 7.89% 73.40% 4.89% 67.04% 45.33% 11.30% 18.65% 60.96%

Quarterly Metrics And Ratios for Parsons

This table displays calculated financial ratios and metrics derived from Parsons' official financial filings.

Metric Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding
- - - - - - - - - - 105,831,019.00
DEI Adjusted Shares Outstanding
- - - - - - - - - - 105,831,019.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - - 0.50
Growth Metrics
- - - - - - - - - - -
Revenue Growth
25.05% 35.46% 30.87% 23.15% 27.60% 16.07% 1.22% -5.16% -10.41% -7.52% -4.07%
EBITDA Growth
21.86% 22.98% 56.09% 29.64% 25.15% 9.73% 28.22% -5.31% -1.47% 9.84% -4.93%
EBIT Growth
31.30% 30.27% 87.85% 45.89% 40.60% 21.83% 38.30% -10.36% -6.32% 7.57% -13.88%
NOPAT Growth
36.62% 40.50% 84.90% 45.78% 37.03% 23.67% 8.15% -13.29% -0.85% 5.70% -13.44%
Net Income Growth
37.20% 59.73% -361.12% 47.38% 43.10% 272.86% 48.72% -12.67% -4.43% 7.83% -20.27%
EPS Growth
55.56% 62.50% -539.13% 65.79% 54.76% 374.36% 62.16% -20.63% -9.23% 8.51% -18.33%
Operating Cash Flow Growth
65.47% 113.25% -605.45% 601.72% 46.89% -33.33% 81.41% -0.88% -45.54% 32.15% 68.61%
Free Cash Flow Firm Growth
49.08% 63.31% 41.45% -0.01% 82.10% -183.95% 1.99% -207.24% -669.93% 74.81% -53.59%
Invested Capital Growth
11.67% 7.53% 13.98% 7.38% 4.62% 16.38% 12.29% 14.78% 13.72% 5.46% 15.10%
Revenue Q/Q Growth
4.58% 5.33% 2.77% 8.78% 8.36% -4.19% -10.38% 1.93% 2.36% -1.11% -7.02%
EBITDA Q/Q Growth
7.12% 0.22% 11.27% 8.52% 3.41% -12.12% 11.25% -6.33% 7.61% -2.04% -3.71%
EBIT Q/Q Growth
8.00% -2.85% 21.96% 14.01% 4.09% -15.82% 12.65% -9.19% 8.79% -3.34% -9.80%
NOPAT Q/Q Growth
11.06% -6.33% 14.56% 22.32% 4.39% -15.47% 15.21% -14.72% 19.37% -7.96% -7.62%
Net Income Q/Q Growth
9.20% -2.93% -258.66% 187.63% 6.03% 152.92% -62.22% -13.81% 16.04% -8.56% -12.81%
EPS Q/Q Growth
10.53% -7.14% -358.97% 162.38% 3.17% 184.62% -67.57% -16.67% 18.00% -13.56% -3.92%
Operating Cash Flow Q/Q Growth
786.06% -6.61% -133.36% 354.22% 85.47% -57.61% -109.30% 1,455.74% 1.91% 2.87% -102.21%
Free Cash Flow Firm Q/Q Growth
-93.02% 41.58% -57.23% 60.51% 65.45% -826.63% 25.17% -28.26% 13.42% 69.81% -358.07%
Invested Capital Q/Q Growth
1.79% -1.23% 6.40% -1.65% -0.82% 9.87% 4.79% 0.52% -1.73% 1.88% 14.36%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
20.74% 24.57% 21.15% 21.04% 19.90% 21.32% 22.77% 21.99% 22.19% 23.03% 23.97%
EBITDA Margin
8.04% 7.65% 8.28% 8.26% 7.88% 7.23% 8.97% 8.25% 8.67% 8.59% 8.89%
Operating Margin
5.87% 5.18% 6.63% 6.67% 6.35% 5.76% 7.03% 6.04% 6.66% 6.56% 6.42%
EBIT Margin
5.86% 5.41% 6.42% 6.72% 6.46% 5.67% 7.13% 6.35% 6.75% 6.60% 6.40%
Profit (Net Income) Margin
4.22% 3.89% -6.00% 4.83% 4.73% 12.48% 5.26% 4.45% 5.04% 4.66% 4.37%
Tax Burden Percent
79.72% 80.35% 74.08% 78.27% 79.17% 77.10% 81.17% 79.04% 83.61% 78.95% 80.21%
Interest Burden Percent
90.23% 89.44% -126.22% 91.82% 92.47% 285.27% 90.89% 88.58% 89.32% 89.49% 85.14%
Effective Tax Rate
20.28% 19.65% 0.00% 21.73% 20.83% 22.90% 18.83% 20.96% 16.39% 21.05% 19.79%
Return on Invested Capital (ROIC)
8.68% 8.27% 9.31% 10.91% 11.13% 9.75% 11.80% 9.80% 11.25% 9.71% 8.71%
ROIC Less NNEP Spread (ROIC-NNEP)
7.58% 7.44% -13.71% 9.95% 10.24% 32.40% 11.02% 9.14% 9.99% 8.60% 7.63%
Return on Net Nonoperating Assets (RNNOA)
2.13% 1.68% -4.46% 2.97% 2.68% 8.13% 4.04% 2.91% 2.65% 2.41% 3.09%
Return on Equity (ROE)
10.81% 9.95% 4.86% 13.88% 13.81% 17.88% 15.84% 12.70% 13.90% 12.12% 11.80%
Cash Return on Invested Capital (CROIC)
-3.35% 1.03% -2.92% 3.67% 6.94% -4.12% -1.02% -3.50% -2.48% 4.63% -5.29%
Operating Return on Assets (OROA)
6.71% 6.54% 7.96% 8.44% 8.26% 7.44% 9.16% 7.75% 7.85% 7.46% 7.04%
Return on Assets (ROA)
4.83% 4.70% -7.44% 6.07% 6.05% 16.37% 6.75% 5.43% 5.86% 5.27% 4.81%
Return on Common Equity (ROCE)
10.49% 9.63% 4.68% 13.35% 13.29% 17.12% 15.23% 12.17% 13.33% 11.56% 11.36%
Return on Equity Simple (ROE_SIMPLE)
8.57% 0.00% 3.75% 4.80% 5.72% 0.00% 12.94% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
66 62 71 87 91 77 89 76 90 83 77
NOPAT Margin
4.68% 4.16% 4.64% 5.22% 5.03% 4.44% 5.70% 4.77% 5.57% 5.18% 5.15%
Net Nonoperating Expense Percent (NNEP)
1.11% 0.83% 23.02% 0.96% 0.89% -22.65% 0.78% 0.65% 1.26% 1.11% 1.07%
Return On Investment Capital (ROIC_SIMPLE)
- 1.92% - - - 1.98% 2.29% 1.87% 2.26% 2.03% 1.73%
Cost of Revenue to Revenue
79.26% 75.43% 78.85% 78.96% 80.10% 78.68% 77.23% 78.01% 77.81% 76.97% 76.03%
SG&A Expenses to Revenue
15.59% 15.90% 14.39% 13.37% 13.60% 15.26% 15.70% 15.91% 16.04% 16.20% 17.97%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
14.87% 19.39% 14.52% 14.37% 13.55% 14.22% 15.75% 15.95% 15.53% 16.47% 17.55%
Earnings before Interest and Taxes (EBIT)
83 81 99 112 117 98 111 101 110 106 95
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
114 114 127 138 143 125 139 131 141 138 133
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
2.62 2.88 4.05 5.41 4.76 4.05 2.58 3.05 3.46 2.49 2.16
Price to Tangible Book Value (P/TBV)
61.09 30.04 90.28 66.87 150.11 0.00 894.62 0.00 161.20 50.82 0.00
Price to Revenue (P/Rev)
1.13 1.21 1.50 1.96 1.69 1.45 0.93 1.15 1.36 1.03 0.91
Price to Earnings (P/E)
39.48 40.82 308.08 221.62 139.93 41.68 24.18 30.98 36.94 27.29 25.16
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
2.53% 2.45% 0.32% 0.45% 0.71% 2.40% 4.14% 3.23% 2.71% 3.66% 3.97%
Enterprise Value to Invested Capital (EV/IC)
2.23 2.51 3.12 4.23 3.89 3.23 2.12 2.48 2.84 2.13 1.77
Enterprise Value to Revenue (EV/Rev)
1.27 1.31 1.66 2.10 1.80 1.58 1.08 1.29 1.50 1.17 1.12
Enterprise Value to EBITDA (EV/EBITDA)
16.22 17.13 20.86 25.98 22.42 20.04 13.00 15.51 17.53 13.53 13.05
Enterprise Value to EBIT (EV/EBIT)
23.32 24.30 28.38 34.21 28.65 25.07 16.05 19.39 22.19 17.39 17.17
Enterprise Value to NOPAT (EV/NOPAT)
30.60 31.40 32.79 40.58 34.72 31.57 21.22 25.86 29.17 21.99 21.70
Enterprise Value to Operating Cash Flow (EV/OCF)
20.87 17.49 27.27 26.08 19.94 20.40 12.74 15.05 22.21 15.52 14.53
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 253.23 0.00 119.26 57.31 0.00 0.00 0.00 0.00 47.24 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.44 0.36 0.63 0.60 0.56 0.54 0.52 0.54 0.50 0.48 0.61
Long-Term Debt to Equity
0.42 0.36 0.60 0.58 0.51 0.35 0.35 0.51 0.50 0.48 0.59
Financial Leverage
0.28 0.23 0.32 0.30 0.26 0.25 0.37 0.32 0.27 0.28 0.41
Leverage Ratio
2.08 2.01 2.14 2.16 2.18 2.10 2.20 2.22 2.20 2.12 2.16
Compound Leverage Factor
1.87 1.80 -2.70 1.98 2.02 5.98 2.00 1.96 1.97 1.90 1.84
Debt to Total Capital
30.71% 26.65% 38.57% 37.61% 35.80% 34.95% 34.29% 35.15% 33.37% 32.49% 37.85%
Short-Term Debt to Total Capital
1.75% 0.00% 1.51% 1.42% 3.07% 11.89% 11.23% 2.10% 0.00% 0.00% 0.97%
Long-Term Debt to Total Capital
28.96% 26.65% 37.06% 36.19% 32.73% 23.06% 23.06% 33.05% 33.37% 32.49% 36.88%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
2.32% 2.76% 2.56% 2.72% 2.71% 3.03% 2.37% 2.62% 2.67% 3.07% 2.36%
Common Equity to Total Capital
66.96% 70.59% 58.87% 59.67% 61.49% 62.02% 63.34% 62.24% 63.96% 64.45% 59.80%
Debt to EBITDA
2.52 2.07 3.05 2.83 2.58 2.55 2.36 2.55 2.41 2.43 3.10
Net Debt to EBITDA
1.59 1.11 1.82 1.44 1.14 1.44 1.63 1.54 1.36 1.31 2.27
Long-Term Debt to EBITDA
2.38 2.07 2.93 2.73 2.36 1.69 1.58 2.40 2.41 2.43 3.02
Debt to NOPAT
4.76 3.80 4.79 4.43 3.99 4.02 3.84 4.25 4.01 3.95 5.15
Net Debt to NOPAT
2.99 2.04 2.86 2.26 1.76 2.27 2.65 2.57 2.27 2.12 3.78
Long-Term Debt to NOPAT
4.49 3.80 4.61 4.26 3.65 2.65 2.59 4.00 4.01 3.95 5.02
Altman Z-Score
2.71 3.06 3.31 4.01 3.71 3.51 2.86 3.05 3.29 2.88 2.54
Noncontrolling Interest Sharing Ratio
3.00% 3.17% 3.55% 3.82% 3.80% 4.23% 3.87% 4.19% 4.11% 4.60% 3.71%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.45 1.52 1.79 1.80 1.55 1.29 1.29 1.61 1.67 1.75 1.75
Quick Ratio
0.80 0.84 1.07 1.10 0.97 0.81 0.75 0.98 1.04 1.04 0.93
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-234 -137 -307 -121 -42 -388 -290 -372 -322 -97 -446
Operating Cash Flow to CapEx
1,601.48% 2,056.16% -672.25% 1,750.37% 2,561.75% 677.31% -87.49% 1,699.83% 1,241.14% 538.07% -24.80%
Free Cash Flow to Firm to Interest Expense
-27.17 -14.97 -1.37 -9.32 -3.21 0.00 -23.71 -29.63 -23.82 -7.52 -27.88
Operating Cash Flow to Interest Expense
23.64 20.83 -0.28 12.39 22.94 0.00 -0.96 12.71 12.03 12.93 -0.23
Operating Cash Flow Less CapEx to Interest Expense
22.16 19.82 -0.33 11.69 22.05 0.00 -2.06 11.97 11.06 10.53 -1.16
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.14 1.21 1.24 1.26 1.28 1.31 1.28 1.22 1.16 1.13 1.10
Accounts Receivable Turnover
6.25 6.67 6.50 6.14 6.71 6.70 6.30 6.05 5.75 5.72 5.67
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
52.12 55.82 60.07 63.25 64.93 64.13 61.47 60.49 57.21 48.46 45.60
Accounts Payable Turnover
17.00 19.07 18.74 19.51 18.03 23.73 18.96 19.40 17.71 21.54 18.68
Days Sales Outstanding (DSO)
58.43 54.76 56.19 59.43 54.43 54.50 57.92 60.37 63.47 63.80 64.34
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
21.48 19.14 19.48 18.71 20.25 15.38 19.25 18.81 20.61 16.95 19.54
Cash Conversion Cycle (CCC)
36.96 35.62 36.71 40.72 34.18 39.12 38.67 41.56 42.87 46.85 44.80
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
2,874 2,839 3,083 3,032 3,007 3,304 3,462 3,480 3,420 3,485 3,985
Invested Capital Turnover
1.85 1.99 2.01 2.09 2.21 2.20 2.07 2.05 2.02 1.88 1.69
Increase / (Decrease) in Invested Capital
300 199 378 208 133 465 379 448 413 180 523
Enterprise Value (EV)
6,402 7,129 9,634 12,819 11,704 10,684 7,331 8,635 9,718 7,423 7,068
Market Capitalization
5,701 6,578 8,701 12,005 11,009 9,796 6,322 7,670 8,855 6,581 5,733
Book Value per Share
$20.72 $21.81 $14.65 $15.12 $21.78 $22.76 $22.98 $23.54 $23.95 $24.81 $25.04
Tangible Book Value per Share
$0.89 $2.09 $0.66 $1.22 $0.69 ($0.15) $0.07 ($0.07) $0.51 $1.22 ($1.72)
Total Capital
3,245 3,240 3,651 3,718 3,761 3,896 3,874 4,042 3,999 4,100 4,431
Total Debt
997 863 1,408 1,398 1,346 1,362 1,328 1,421 1,334 1,332 1,677
Total Long-Term Debt
940 863 1,353 1,345 1,231 898 894 1,336 1,334 1,332 1,634
Net Debt
626 462 840 713 593 770 916 859 755 717 1,231
Capital Expenditures (CapEx)
13 9.25 9.43 9.21 12 19 13 9.40 13 31 15
Debt-free, Cash-free Net Working Capital (DFCFNWC)
473 454 705 671 462 557 701 660 639 685 873
Debt-free Net Working Capital (DFNWC)
678 727 1,129 1,200 1,021 1,010 971 1,071 1,061 1,152 1,157
Net Working Capital (NWC)
621 727 1,074 1,147 905 547 536 986 1,061 1,152 1,115
Net Nonoperating Expense (NNE)
6.63 4.17 163 6.49 5.45 -140 6.87 5.12 8.47 8.28 12
Net Nonoperating Obligations (NNO)
626 462 840 713 593 770 916 859 755 717 1,231
Total Depreciation and Amortization (D&A)
31 33 29 26 26 27 29 30 31 32 37
Debt-free, Cash-free Net Working Capital to Revenue
9.36% 8.34% 12.15% 10.97% 7.09% 8.25% 10.35% 9.87% 9.83% 10.77% 13.86%
Debt-free Net Working Capital to Revenue
13.43% 13.35% 19.44% 19.60% 15.68% 14.96% 14.34% 16.03% 16.34% 18.10% 18.37%
Net Working Capital to Revenue
12.30% 13.35% 18.49% 18.74% 13.90% 8.10% 7.91% 14.76% 16.34% 18.10% 17.69%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.45 $0.43 ($1.01) $0.65 $0.68 $1.89 $0.62 $0.52 $0.60 $0.52 $0.49
Adjusted Weighted Average Basic Shares Outstanding
104.89M 105.83M 146.75M 106.19M 106.19M 106.78M 106.87M 106.79M 106.49M 105.83M 106.98M
Adjusted Diluted Earnings per Share
$0.42 $0.39 ($1.01) $0.63 $0.65 $1.85 $0.60 $0.50 $0.59 $0.51 $0.49
Adjusted Weighted Average Diluted Shares Outstanding
104.89M 105.83M 146.75M 106.19M 106.19M 106.78M 106.87M 106.79M 106.49M 105.83M 106.98M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
104.89M 105.83M 146.75M 106.19M 106.19M 106.78M 106.87M 106.79M 106.49M 105.83M 106.98M
Normalized Net Operating Profit after Tax (NOPAT)
66 62 71 87 91 77 89 76 90 83 77
Normalized NOPAT Margin
4.68% 4.16% 4.64% 5.22% 5.03% 4.44% 5.70% 4.77% 5.57% 5.18% 5.15%
Pre Tax Income Margin
5.29% 4.84% -8.10% 6.17% 5.97% 16.19% 6.48% 5.63% 6.03% 5.91% 5.45%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
9.66 8.85 0.44 8.63 8.97 0.00 9.05 8.01 8.09 8.17 5.97
NOPAT to Interest Expense
7.71 6.82 0.32 6.70 6.98 0.00 7.24 6.02 6.67 6.41 4.80
EBIT Less CapEx to Interest Expense
8.18 7.84 0.40 7.93 8.07 0.00 7.95 7.26 7.12 5.77 5.04
NOPAT Less CapEx to Interest Expense
6.24 5.80 0.28 6.00 6.09 0.00 6.14 5.27 5.70 4.01 3.86
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
11.81% 6.01% 28.71% 23.72% 22.19% 10.05% 18.88% 19.21% 20.77% 20.49% 18.78%
Augmented Payout Ratio
17.45% 11.30% 34.92% 35.93% 32.02% 18.65% 34.63% 37.11% 47.13% 60.96% 64.96%

Financials Breakdown Chart

Key Financial Trends

Below is a concise, investor‑focused view of Parsons Corp (PSN) based on quarterly statements over the last four fiscal years. The goal is to highlight meaningful year‑over‑year trends in revenue, profitability, cash flow, and the balance sheet that could impact risk and upside for retail investors.

  • Gross margin anchored by a higher gross profit percentage in late‑2025. Q4 2025 shows Total Revenue of 1,603,814,000 with Total Gross Profit of 369,343,000, implying a gross margin around 23%. This compares with about 21% in Q4 2024 (Gross Profit 369,752,000 on Revenue 1,734,316,000), signaling margin improvement despite flat to modestly lower quarterly revenue.
  • Operating margin improvement into late 2025. Q4 2025 shows Total Operating Income of 105,225,000 on 1,603,814,000 revenue (~6.6% operating margin), modestly stronger than the prior year’s periods, suggesting improved operating leverage.
  • Cash flow from operations trending up in 2025. Net Cash From Continuing Operating Activities rose across the year (Q2 2025: 159,801,000; Q3 2025: 162,850,000; Q4 2025: 167,518,000), signaling improving operating cash generation after earlier volatility.
  • Liquidity improving in 2025: higher cash balance observed in mid‑2025. Cash & Equivalents stood around 422.6 million in Q3 2025, up from earlier quarters in 2025, indicating stronger liquidity headroom.
  • Deleveraging signals: short‑term debt largely eliminated by mid‑2025. Short‑term debt is reported as 0.0 by Q3 2025 balance sheet, reducing near‑term liquidity risk and rollover concerns.
  • Capital returns to shareholders in 2025. Financing activity included notable share repurchases in 2025 (e.g., Q3 2025 and Q4 2025 show meaningful repurchases; Q4 2025 lists a substantial equity repurchase). This can be a positive for shareholders, though it uses cash that could otherwise be deployed for growth or debt repayment.
  • Free cash flow potential remains positive in late 2025. In Q4 2025, Net Cash From Operating Activities was 167,518,000 and capital expenditures (Purchase of Property, Plant & Equipment) were about 31,940,000, implying approximate quarterly free cash flow around 135–136 million, a constructive signal for liquidity and potential deleveraging over time.
  • Revenue scale and stability across years. Across the last four years, quarterly Revenue generally runs in the low‑to‑mid‑1.6 billion range with periodic variability, indicating a stable cash generation base without dramatic swings. This can offer steadier long‑term visibility than highly cyclical peers.
  • Balanced asset base with sizable goodwill and intangible assets. The Q3 2025 balance sheet shows goodwill around 2.163–2.164 billion and intangible assets around 339–343 million, plus a large level of total assets (~5.736 billion). While not immediately negative, these high non‑cash assets warrant monitoring for impairment risk if demand weakens.
  • Debt level remains meaningful but stable. Long‑term debt sits near 1.236–1.245 billion across 2025 quarters, with total liabilities and equity structure showing gradual changes but no dramatic deleveraging yet. This provides a baseline for evaluating future capital allocation decisions and potential leverage risk.
  • Net income trends weakened in 2025 vs. 2024. Net income attributable to common shareholders was 55,583,000 in Q4 2025 vs. 66,203,000 in Q4 2024; similarly, Q3 2025 net income to common shareholders was 64,123,000 vs. 71,951,000 in Q3 2024. The bottom line has softened despite stable revenue, signaling pressure on profitability that warrants watching.
  • Financing outflows persist, weighing on free cash flow in 2025. Net cash from financing activities remained negative in 2025 (e.g., Q4 2025 net financing cash flow around −57.6 million; Q3 2025 around −127.3 million), reflecting ongoing share repurchases and debt adjustments that reduce cash available for other uses.
05/15/26 06:52 AM ETAI Generated. May Contain Errors.

Parsons Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Parsons' fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Parsons' net income appears to be on an upward trend, with a most recent value of $308.86 million in 2025, rising from $111.54 million in 2017. The previous period was $290.67 million in 2024. Check out Parsons' forecast to explore projected trends and price targets.

Parsons' total operating income in 2025 was $418.07 million, based on the following breakdown:
  • Total Gross Profit: $1.43 billion
  • Total Operating Expenses: $1.01 billion

Over the last 8 years, Parsons' total revenue changed from $3.02 billion in 2017 to $6.36 billion in 2025, a change of 110.9%.

Parsons' total liabilities were at $3.00 billion at the end of 2025, a 1.6% increase from 2024, and a 81.1% increase since 2018.

In the past 7 years, Parsons' cash and equivalents has ranged from $182.69 million in 2019 to $483.61 million in 2020, and is currently $466.39 million as of their latest financial filing in 2025.

Over the last 8 years, Parsons' book value per share changed from 0.00 in 2017 to 24.81 in 2025, a change of 2,481.0%.



Financial statements for NYSE:PSN last updated on 5/2/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners